Reduction of severe oropharyngeal hemorrhage following transoral robotic surgery

The epidemic of human papillomavirus-associated-oropharyngeal carcinoma (HPV OPSCC) has significantly impacted the practice of head and neck surgical oncology. The rising rates of this disease, younger age and better prognosis have charged our community to explore de-intensification treatment modalities particularly as a growing population will suffer from the long term sequelae of treatment for a greater period of time. Concurrent chemoradiation therapy (CCRT) has become a standard of care but the improved survival conferred with this modality has a price of increasing rates of early and late toxicities [1,2].

http://ift.tt/2trnPqP